{"id":"W4400247649","doi":"10.1002/cam4.7415","title":"Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018–2021) compared to the sorafenib era (2008–2018)","year":2024,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Lenvatinib; Medicine; Sorafenib; Internal medicine; Hepatocellular carcinoma; Bevacizumab; Atezolizumab; Progression-free survival; Oncology; Overall survival; Gastroenterology; Cancer; Nivolumab; Immunotherapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003848224,0.0001801058,0.0002881863,0.000535718,0.0003455451,0.0004395617,0.0002293855,0.0002719728,0.0009167897],"category_scores_gemma":[0.0009512343,0.0001088002,0.0003649477,0.0006094655,0.0002528809,0.0003655832,0.0004251163,0.0005430952,0.0001767721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001334115,"about_ca_system_score_gemma":0.0008731551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0114082,"about_ca_topic_score_gemma":0.02146342,"domain_scores_codex":[0.9997278,0.0000364897,0.00002351534,0.00005143301,0.00006298207,0.00009792698],"domain_scores_gemma":[0.9989127,0.00008490233,0.0005840065,0.00002088326,0.0001160212,0.000281607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001159774,0.00008788804,0.9961282,0.00001289129,0.00005029093,0.0001235871,0.0000861486,0.0001055351,0.0002075891,0.0000197607,0.0002184392,0.001799915],"study_design_scores_gemma":[0.00004838229,0.0007065716,0.9978698,0.000008100048,0.00004635058,0.0003496807,0.0003201712,0.0002023489,0.0001030284,0.00002127493,0.0003180634,0.000006195969],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993742,0.0001193369,0.000009106579,0.00002889578,0.000004578669,0.000004243737,0.0002111623,8.805048e-7,0.0002477228],"genre_scores_gemma":[0.9989814,0.00007170539,0.00001065686,0.00001801719,0.00001264592,0.000007672304,0.0007742314,7.297844e-7,0.000122904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0114082,"threshold_uncertainty_score":0.02268362,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05650383963329626,"score_gpt":0.2865017736609094,"score_spread":0.2299979340276131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}